Search results

Showing 14141 - 14150 of 15294 for "KWM Europe" with applied filters

Filters:

News & Analysis

Expiration of the Term of Office of Board Members

03 January 2019 by Gönenç Gürkaynak, Esq., Nazlı Nil Yukaruç, Büşra Üstüntaş of ELIG Gürkaynak Attorneys-at-Law

As per Article 362 of the Turkish Commercial Code No. 6102 (“TCC”), board members are elected for a maximum term of three (3) years.

News & Analysis

IFLR 2018 M&A Report: Luxembourg

19 December 2018 by GSK Stockmann

IFLR 2018 M&A Report: Luxembourg

News & Analysis

IFLR 2018 M&A Report: Austria

19 December 2018 by Fellner Wratzfeld & Partner

IFLR 2018 M&A Report: Austria

News & Analysis

IFLR 2018 M&A Report: Turkey

19 December 2018 by Erdem & Erdem

IFLR 2018 M&A Report: Turkey

News & Analysis

IFLR 2018 M&A Report: UK

19 December 2018 by Cleary Gottlieb Steen & Hamilton

IFLR 2018 M&A Report: UK

News & Analysis

Dispute Resolution Special Focus: Shift in responsibility

18 December 2018 by SRS Advogados

Dispute Resolution Special Focus: Shift in responsibility

News & Analysis

Cross-border financing report: UK

18 December 2018 by Latham & Watkins

Cross-border financing report: UK

News & Analysis

Global Banking & Financial Policy Review 2018/19: Angola signals a new era for foreign investors

18 December 2018 by Morais Leitão Galvão Teles Soares da Silva & Associados

Global Banking & Financial Policy Review 2018/19: Angola signals a new era for foreign investors

News & Analysis

Global Banking & Financial Policy Review 2018/19: Mozambique loosens bureaucracy and eases FDI

18 December 2018 by Morais Leitão Galvão Teles Soares da Silva & Associados

Global Banking & Financial Policy Review 2018/19: Mozambique loosens bureaucracy and eases FDI

News & Analysis

GSK Stockmann appoints its first International Partner and elects new co-Managing Partner

12 December 2018 by GSK

At the end of November 2018, GSK Stockmann’s Partners elected Andreas Heinzmann as International Partner and Dr. Uwe Jäger as new co-Managing Partner. These nominations underpin GSK’s commitment to internationaliza-tion and the consistent implementation of the modernization course the firm set out on.